227 related articles for article (PubMed ID: 32059072)
1. The multicomponent medication Spascupreel attenuates stress-induced gut dysfunction in rats.
Theodorou V; Beaufrand C; Yvon S; Laforge G; Burmeister Y; Müller A; Seilheimer B; Bueno L; Eutamene H
Neurogastroenterol Motil; 2020 May; 32(5):e13798. PubMed ID: 32059072
[TBL] [Abstract][Full Text] [Related]
2. [Effects of heat-sensitive moxibustion on HPA axis in rats with irritable bowel syndrome].
Zhang H; Xie F; Gong H; Huang H; Chen S; Kang M; Fu Y
Zhongguo Zhen Jiu; 2017 Dec; 37(12):1315-21. PubMed ID: 29354998
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.
Chang L; Sundaresh S; Elliott J; Anton PA; Baldi P; Licudine A; Mayer M; Vuong T; Hirano M; Naliboff BD; Ameen VZ; Mayer EA
Neurogastroenterol Motil; 2009 Feb; 21(2):149-59. PubMed ID: 18684212
[TBL] [Abstract][Full Text] [Related]
4. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.
Ait-Belgnaoui A; Durand H; Cartier C; Chaumaz G; Eutamene H; Ferrier L; Houdeau E; Fioramonti J; Bueno L; Theodorou V
Psychoneuroendocrinology; 2012 Nov; 37(11):1885-95. PubMed ID: 22541937
[TBL] [Abstract][Full Text] [Related]
5. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
Kano M; Muratsubaki T; Van Oudenhove L; Morishita J; Yoshizawa M; Kohno K; Yagihashi M; Tanaka Y; Mugikura S; Dupont P; Ly HG; Takase K; Kanazawa M; Fukudo S
Sci Rep; 2017 Sep; 7(1):12425. PubMed ID: 28963545
[TBL] [Abstract][Full Text] [Related]
6. A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
Moussa L; Bézirard V; Salvador-Cartier C; Bacquié V; Houdeau E; Théodorou V
Clin Nutr; 2013 Feb; 32(1):51-8. PubMed ID: 22727545
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.
Liu YW; Wang YP; Yen HF; Liu PY; Tzeng WJ; Tsai CF; Lin HC; Lee FY; Jeng OJ; Lu CL; Tsai YC
Probiotics Antimicrob Proteins; 2020 Sep; 12(3):980-993. PubMed ID: 31691208
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
Itomi Y; Tanaka T; Matsushita K; Kawamura T; Kojima T; Aso K; Matsumoto-Okano S; Tsukimi Y
Neurogastroenterol Motil; 2020 May; 32(5):e13795. PubMed ID: 31970891
[TBL] [Abstract][Full Text] [Related]
10. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS).
Zou N; Lv H; Li J; Yang N; Xue H; Zhu J; Qian J
Transl Res; 2008 Dec; 152(6):283-9. PubMed ID: 19059163
[TBL] [Abstract][Full Text] [Related]
11. The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression.
Videlock EJ; Shih W; Adeyemo M; Mahurkar-Joshi S; Presson AP; Polytarchou C; Alberto M; Iliopoulos D; Mayer EA; Chang L
Psychoneuroendocrinology; 2016 Jul; 69():67-76. PubMed ID: 27038676
[TBL] [Abstract][Full Text] [Related]
12. [Electroacupuncture Relieves Visceral Hypersensitivity by Down-regulating Mast Cell Number，PAR-2/TRPV 1 Signaling, etc. in Colonic Tissue of Rats with Irritable Bowel Syndrome].
Deng DX; Tan J; Zhang H; Huang GL; Li S; Guo KK; Wu YY; Yang BY; Xiao Y; Peng L; Xie H
Zhen Ci Yan Jiu; 2018 Aug; 43(8):485-91. PubMed ID: 30232850
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
14. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
[TBL] [Abstract][Full Text] [Related]
15. Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome.
Heitkemper MM; Cain KC; Deechakawan W; Poppe A; Jun SE; Burr RL; Jarrett ME
Neurogastroenterol Motil; 2012 Jul; 24(7):626-31, e270-1. PubMed ID: 22471712
[TBL] [Abstract][Full Text] [Related]
16. Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.
Coss-Adame E; Rao SS
Curr Gastroenterol Rep; 2014 Apr; 16(4):379. PubMed ID: 24595616
[TBL] [Abstract][Full Text] [Related]
17. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
Fukudo S
J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
[TBL] [Abstract][Full Text] [Related]
18. Altered psychobiological responsiveness in women with irritable bowel syndrome.
Suárez-Hitz KA; Otto B; Bidlingmaier M; Schwizer W; Fried M; Ehlert U
Psychosom Med; 2012; 74(2):221-31. PubMed ID: 22286854
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
Dinan TG; Quigley EM; Ahmed SM; Scully P; O'Brien S; O'Mahony L; O'Mahony S; Shanahan F; Keeling PW
Gastroenterology; 2006 Feb; 130(2):304-11. PubMed ID: 16472586
[TBL] [Abstract][Full Text] [Related]
20. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
